Plain-English translation of NCT07269223 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether supplements can help reduce inflammation in people with moderate ulcerative colitis, a condition that causes painful bowel symptoms. Many patients with this condition have very low vitamin D levels, and researchers believe that may help calm the body's overactive immune response and improve how well current treatments work.
People with ulcerative colitis often have severely low vitamin D levels, and early research suggests this medication may help reduce inflammation and ease symptoms. This trial aims to confirm whether the treatment is truly effective for patients in Pakistan with moderate disease.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either capsules or a placebo (inactive pill) taken every two weeks. Throughout the study, you'll have follow-up visits where researchers will check your vitamin D levels, monitor your bowel symptoms using a simple scoring system, and collect blood and stool samples to measure inflammation markers. The study will help doctors understand whether this supplement can reduce your symptoms and improve your quality of life.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Pakistan